If confirmed as Secretary of Health and Human Services under President-elect Donald Trump, Robert F. Kennedy Jr. would hold substantial influence over the nation’s vaccine policies. This position would grant him oversight of key programs and regulatory processes, including the Vaccines for Children program, credited with saving millions of lives by providing immunizations against diseases like polio and measles.
Kennedy’s potential appointment has sparked concern among public health experts due to his history of controversial statements about vaccines. Critics argue that his views could undermine decades of evidence-based practices and public trust in vaccines. “A serious candidate for this position would follow the decades of real-world evidence that shows that vaccines are safe and prevent as many as 5 million deaths each year,” said Dr. Georges Benjamin, executive director of the American Public Health Association.
Kennedy’s Vaccine Stance Raises Alarm
Kennedy denies being “anti-vaccine,” yet his record suggests otherwise. He has repeatedly linked vaccines to autism, despite overwhelming scientific evidence debunking this claim. In 2005, he authored a now-retracted article falsely alleging a connection between autism and a discontinued vaccine ingredient. More recently, he labeled COVID-19 vaccines as “a crime against humanity” and questioned the need for children to receive them, despite research estimating the shots prevented 3.2 million deaths in the U.S. alone by 2022.
Kennedy chaired Children’s Health Defense, an organization widely criticized for the most prolific spreading of vaccine misinformation. While he has vowed to promote transparency and data accessibility, many fear his leadership could amplify vaccine skepticism. His proposed plans include reorganizing federal health agencies to address what he calls “corruption” that compromises scientific integrity.
CDC’s Role in Vaccine Recommendations
The Centers for Disease Control and Prevention (CDC) plays a critical role in determining which vaccines are required to be covered by health insurance. Its Advisory Committee on Immunization Practices, composed of medical experts, evaluates the safety and efficacy of vaccines during public meetings. The Committee's findings guide nearly all insurance providers nationwide, who are required by law to cover the routine shots recommended. But, Kennedy could alter the process significantly.
As HHS Secretary, Kennedy would have the authority to appoint members to the advisory committee and could even override its recommendations. His appointee to lead the CDC could also impact key programs like Vaccines for Children, which ensures access to vaccines for uninsured children, and the agency’s efforts to track immunization rates and monitor vaccine safety.
Oversight at the FDA
The Food and Drug Administration (FDA) also falls under the HHS Secretary’s purview, giving Kennedy indirect control over vaccine approvals and regulations. While career scientists typically handle these decisions, political leaders can intervene. According to Dr. Robert Califf, the FDA Commissioner, “It’s totally within the law for the president or the HHS secretary to overrule the entire FDA.”
Kennedy’s choice for FDA leadership could influence guidance for vaccine manufacturers and delay or block regulatory changes. The agency’s ability to maintain its scientific independence under Kennedy’s leadership remains a pressing question for public health advocates.
Shaping Public Perception of Vaccines
Kennedy’s influence extends beyond policy decisions to how Americans perceive vaccine risks and benefits. The HHS oversees public health campaigns that promote immunizations and address vaccine hesitancy. Communication strategies are especially critical in preventing outbreaks of diseases like polio, which reemerged in New York in 2022 after decades of eradication.
Explaining vaccine risks while maintaining public trust is another challenge. For instance, federal agencies faced scrutiny when investigating a potential link between COVID-19 vaccines and stroke in seniors. Although subsequent analyses found no evidence of increased risk, experts stress the importance of clear and balanced communication to sustain confidence in vaccination programs.
Kennedy’s leadership could shape how vaccine data is presented, potentially shifting public opinion on immunization efforts nationwide.